Ctxr stock forecast.

The Citius Pharmaceuticals stock forecast is 1.4743344248155 USD for 2024 November 22, Friday; and 4.601 USD for 2028 November 22, Wednesday with technical analysis. Citius Pharmaceuticals (CTXR) stock price prediction is 1.4743344248155 USD.Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.CTXR Stock Forecast, Price Targets and Analysts Predictions Based on 2 Wall Street analysts offering 12 month price targets for Citius Pharmaceuticals in the last 3 months. The average price target is $7.00 with a high ...Analyst Forecast. According to one analyst, the rating for CTXR stock is "Strong Buy" and the 12-month stock price forecast is $4.0.Nov 30, 2023 · CTXR is trading at a 62% discount. Price $0.76 Nov 30, 2023 Fair Value $4.92 Nov 30, 2023 Uncertainty Extreme 1-Star Price $7.89

See the CTXR stock price predictions generated by our AI models, including high, low and average values. These predictions can range from one-week to monthly, or even 12-month, time spans. According to our price prediction algorithm,Citius Pharmaceuticals, Inc. (CTXR) price will be around $1.61 in the next 2 weeks..View Citius Pharmaceuticals, Inc CTXR investment & stock information. Get the latest Citius Pharmaceuticals, Inc CTXR detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Paid Partner. Find real-time CTXR - Citius Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business.

For Citius Pharmaceuticals stock forecast for 2023, 1 predictions are offered for each month of 2023 with average Citius Pharmaceuticals stock forecast of $0.79, a high forecast of $0.79, and a low forecast of $0.79. The average Citius Pharmaceuticals stock forecast 2023 represents a 2.65% increase from the last price of $0.771899998188019.Citius Pharmaceuticals Inc Stock Price Forecast, "CTXR" Predictons for2027 Forecast Crypto Forecasts Top 5 Crypto forecasts Tether Usdt forecast Bitcoin forecast Ethereum forecast First Digital Usd forecast Xrp forecastSee Citius Pharmaceuticals, Inc. (CTXR) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. CTXR Stock Forecast: Analysts Predict 354.60% Increase in Value over Next 12 Months. On September 8, 2023, Citius Pharmaceuticals Inc (CTXR) had a median target price of $4.00, according to three analysts offering 12-month price forecasts. The high estimate for the stock was $8.00, while the low estimate stood at $4.00.

Find the latest Earnings Report Date for Citius Pharmaceuticals, Inc. Common Stock (CTXR) at Nasdaq.com. Skip to main content ... Read our earnings report guide before you consider the forecast ...

Dec 3, 2023 · Citius Pharmaceuticals didn't record any revenue over the last year, indicating that it's an early stage company still developing its business. Nonetheless, we can still examine its cash burn ...

Citius Pharmaceuticals Inc Stock Price Forecast, "CTXR" Predictons for2024 Forecast Crypto Forecasts Top 5 Crypto forecasts Tether Usdt forecast Bitcoin forecast Ethereum forecast Binance Usd forecast Solana forecastRetails investors are very fomoy, things could get stupid really fast when people start to know the potential. Specially with the internet age, things spread like wild fire. If some good catalyst happens and bombs drop. I agree with all your other predictions apart from eoy and next year.View the latest CTXR earnings date, analysts forecasts, earnings history, and conference call transcripts. Skip to main content S&P 500 4,594.63 DOW 36,245.50 QQQ 389.94 MarketBeat Week in Review – 11/27 - 12/1 ...Stock Price Forecast. The 15 analysts offering 12-month price forecasts for Curaleaf Holdings Inc have a median target of 4.70, with a high estimate of 13.22 and a low estimate of 2.75. The median ... For Citius Pharmaceuticals stock forecast for 2023, 1 predictions are offered for each month of 2023 with average Citius Pharmaceuticals stock forecast of $0.79, a high forecast of $0.79, and a low forecast of $0.79. The average Citius Pharmaceuticals stock forecast 2023 represents a 2.65% increase from the last price of $0.771899998188019. Miscellaneous Commercial Services. No executives to display. Corporate headquarters. New York, New York. Find real-time BTBT - Bit Digital Inc stock quotes, company profile, news and forecasts ...

View the latest CTXR earnings date, analysts forecasts, earnings history, and conference call transcripts. Skip to main content S&P 500 4,594.63 DOW 36,245.50 QQQ 389.94 MarketBeat Week in Review – 11/27 - 12/1 ...View the latest Citius Pharmaceuticals Inc. (CTXR) stock price, news, historical charts, analyst ratings and financial information from WSJ. According to 18 stock analysts, the average 12-month stock price forecast for Chevron stock is $188.72, which predicts an increase of 30.24%. The lowest target is $169 and the highest is $212. On average, analysts rate Chevron stock as a buy.0.673%. $63.90. Check if ABML Stock has a Buy or Sell Evaluation. ABML Stock Price (OTCBB), Forecast, Predictions, Stock Analysis and American Battery News.Stock Price Market cap Dividend Forecast Employees Revenue Stories Citius Pharmaceuticals, Inc. (CTXR) Stock Price Forecast Citius Pharmaceuticals, Inc. (CTXR) average Stock Price Forecast target 2023 is $-0.40 with a high forecast of $-1.11 and a …CTXR is trading at a 62% discount. Price $0.76 Nov 30, 2023 Fair Value $4.92 Nov 30, 2023 Uncertainty Extreme 1-Star Price $7.89

Based on short-term price targets offered by three analysts, the average price target for Citius Pharmaceuticals, Inc. comes to $5.33. The forecasts range from a low of $4.00 to a high of $8.00 ...

You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.iStock offer stock information, like fair price, target price and crucial economic indicator to help investor to find the best stock 10 Things to Know About the Deal Taking Citrix Systems Private Furthermore, shareholders of CTXS stock will receive $104 per share, which is lower than last Friday's closing price of $105.55.PDUFA; it has generated excitement among investors, but I believe it is unlikely to generate alpha. Read why CTXR is a ... Near term PDUFA's on penny stocks, as I write on 06/01/2023 Citius hovers ...Citius Pharmaceuticals Inc Stock Price Forecast, "CTXR" Predictons for2024CTXR Overview Stock Screener Earnings Calendar Sectors Nasdaq | CTXR U.S.: Nasdaq Citius Pharmaceuticals Inc. Watch list NEW Set a price target alert After Hours Last Updated: Nov 24, 2023...May 5, 2023 · CTXR stock closed at $1.25 and is up $0.04 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. CTXR has a strong overall score of 83May 5, 2023 · CTXR stock closed at $1.25 and is up $0.04 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. CTXR has a strong overall score of 83A high-level overview of Citius Pharmaceuticals, Inc. (CTXR) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Apr 17, 2023 · The put/call ratio of CTXR is 0.03, indicating a bullish outlook. Analyst Price Forecast Suggests 314.64% Upside As of April 7, 2023, the average one-year price target for Citius Pharmaceuticals ... Find the latest ClearBridge MLP and Midstream T CTR analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range investment rating ...

Citius Pharmaceuticals Inc (CTXR) current stock price is $0.77. During the last trading session, the stock soared, reaching $0.6901 after opening at $0.67. The stock’s lowest point was $0.65 before it closed at $0.67. #1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2023-24. The New Uranium Bull Market is here, and you're right on time for ...

Citius Pharmaceuticals Market Cap: 150.02M, Enterprise value: N/A, P/E: -6.95, PEG ratio: N/A, EPS: -73309.72, Revenue: N/A, EBITDA: -34.34M, Income: -34.85M, Profit

For Citius Pharmaceuticals stock forecast for 2023, 1 predictions are offered for each month of 2023 with average Citius Pharmaceuticals stock forecast of $0.79, a high forecast of $0.79, and a low forecast of $0.79. The average Citius Pharmaceuticals stock forecast 2023 represents a 2.65% increase from the last price of $0.771899998188019. Citius Pharmaceuticals Inc Stock Price Forecast, "CTXR" Predictons for2028 Forecast Crypto Forecasts Top 5 Crypto forecasts Bitcoin forecast Ethereum forecast Xrp forecast Binance Usd forecast Weth forecast Stock Forecasts (US)See Citius Pharmaceuticals, Inc. (CTXR) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. 0.673%. $63.90. Check if SURF Stock has a Buy or Sell Evaluation. SURF Stock Price (NASDAQ), Forecast, Predictions, Stock Analysis and Surface Oncology Inc. News.View live Citius Pharmaceuticals, Inc. chart to track its stock's price action. Find market predictions, CTXR financials and market news. CTXR 15Min Scalper's edition test Citius Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives in adjunct …View Citius Pharmaceuticals, Inc CTXR investment & stock information. Get the latest Citius Pharmaceuticals, Inc CTXR detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Aug 21, 2023 · Earnings vs Market: CTXR is forecast to become profitable over the next 3 years, which is considered above average market growth. High Growth Earnings: CTXR is expected to become profitable in the next 3 years. Revenue vs Market: CTXR's revenue (47.9% per year) is forecast to grow faster than the US market (7.9% per year). Jul 1, 2021 · Shares of Citius Pharmaceuticals ( CTXR 2.84%), a clinical-stage biopharmaceutical company, are getting beaten down today after the company released disappointing news regarding its lead candidate ... The average price target for Citius Pharmaceuticals is $4.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $4.00 ,the lowest forecast is $4.00. The average price target represents 415.40% Increase from the current price of $0.776.CTXR - Stock evaluation, ranks. stock price history, forecast, predictions, news and dividends - Citius Pharmaceuticals Inc. 1-877-778-8358 Features Features Find opportunities Track & manage Collaborate Learn Functions Templates Pricing Help HelpThe yield on the 10-Year Treasury moved up sharply as the January BLS Jobs report showed 517,000 jobs were created in the first month of 2023 and the unemployment rate fell to 3. Get the latest ...

March 19, 2021 at 12:19 pm EDT. NASDAQ: CTXR. Investor Relations Contact:Andrew Scott, VP Special Projects. (908) 967-6677 [email protected]. Citius Pharmaceuticals, Inc. (Nasdaq: CTXR)is a specialty pharmaceutical company dedicated to the development and commercialization of drug products that address important unmet medical needs ...The stock counts as 7.3% of the portfolio, making it one of ARK Innovation's largest positions. Stock Market Forecast For Next 6 Months: What Wall Street Pros Are Monitoring Now.Find the latest Earnings Report Date for Citius Pharmaceuticals, Inc. Common Stock (CTXR) at Nasdaq.com. Skip to main content ... Read our earnings report guide before you consider the forecast ...Instagram:https://instagram. how to buy costco sharessoftware to buy and sell stocks automaticallymortgage reitsembracepet Citius Pharmaceuticals - CTXR Stock Forecast, Price & News Their CTXR share price forecasts range from $4.00 to $6.00. On average, they predict the company's share price to reach $5.00 in the next year.... Forecast–2028”. >4 million. CLABSI's per year*. Market Opportunity. Page 15. 15 ... CTXR STOCK PRICE*. MARKET CAP. $290M. CURRENT PRICE. $2.18. 52 WEEK HIGH. best state 529 planacciones de inteligencia artificial Jun 23, 2021 · Shares of Citius Pharmaceuticals ( CTXR -6.48%) have shot about 270% higher this year. That's an amazing run for a biotech stock that most of us hadn't even heard of yet. Now that the stock has ... commercial real estate bear etf See the CTXR stock price predictions generated by our AI models, including high, low and average values. These predictions can range from one-week to monthly, or even 12-month, time spans. According to our price prediction algorithm,Citius Pharmaceuticals, Inc. (CTXR) price will be around $1.61 in the next 2 weeks..Based on short-term price targets offered by three analysts, the average price target for Citius Pharmaceuticals, Inc. comes to $5.33. The forecasts range from a low of $4.00 to a high of $8.00 ...